Geneos Wealth Management’s Howard Bancorp, Inc. Common Stock HBMD Stock Holding History

Geneos Wealth Management’s Portfolio HBMD Stock Details HBMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-169	Closed	-$3K	–	3074
2021 Q4	$3K	Hold	169	–	–	﹤0.01%	2557
2021 Q3	$3K	Hold	169	–	–	﹤0.01%	2620
2021 Q2	$2K	Hold	169	–	–	﹤0.01%	2716
2021 Q1	$2K	Hold	169	–	–	﹤0.01%	2970
2020 Q4	$2K	Hold	169	–	–	﹤0.01%	2748
2020 Q3	$1K	Hold	169	–	–	﹤0.01%	2611
2020 Q2	$1K	Hold	169	–	–	﹤0.01%	2545
2020 Q1	$1K	Buy	+169	New	+$2.63K	﹤0.01%	2455

Geneos Wealth Management's HBMD Position: Q1 2022 in Review

Geneos Wealth Management sold out of Howard Bancorp, Inc. Common Stock (HBMD) in Q1 2022, closing a stake of 169 shares — an estimated $3K sold.

Geneos Wealth Management first reported a position in HBMD in Q1 2020 and held it in 8 quarters. The position peaked at $3K in Q4 2021. 0 funds tracked by Wall St. Rank hold HBMD as of Q1 2022.

Geneos Wealth Management reported no remaining Howard Bancorp, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Geneos Wealth Management sold 169 Howard Bancorp, Inc. Common Stock shares in Q1 2022, an estimated $3K.
Geneos Wealth Management first reported a position in Howard Bancorp, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
Geneos Wealth Management's Howard Bancorp, Inc. Common Stock position peaked at $3K in Q4 2021.
0 funds tracked by Wall St. Rank held Howard Bancorp, Inc. Common Stock as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.